For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250225:nRSY2497Ya&default-theme=true
RNS Number : 2497Y Tharisa PLC 25 February 2025
Tharisa plc
(Incorporated in the Republic of Cyprus with limited liability)
(Registration number HE223412)
JSE share code: THA
LSE share code: THS
A2X share code: THA
ISIN: CY0103562118
LEI: 213800WW4YWMVVZIJM90
('Tharisa' or the 'Company')
Dealing in securities by director of a major subsidiary
Further to the announcement released on 11 December 2024 regarding the vesting
and settlement of the 2021 Award on 6 December 2024, Tharisa advises that the
below participant had subsequently elected for the Company to settle his tax
liability, thereby reducing the number of shares being equity settled from
66 110 shares as announced on 11 December 2024, to 47 599 shares as detailed
below.
Update to vesting and settlement of LTIPs granted on 8 December 2021
1. Details of director/PDMR
a. Name: Marios Tavros
2. Reason for notification
a. Position/status: Executive director - Arxo Resources Limited
b. Initial notification/amendment: Amendment to initial notification
3. Details of issuer
a. Company name: Tharisa plc
b. LEI: 213800WW4YWMVVZIJM90
4. Details of transaction
a. Description of instrument: Ordinary shares of US$0.001
Identification code: CY0103562118
b. Nature of transaction Off-market vesting and settlement of Conditional Awards in shares
c. Price and volume: Price: Volume:
ZAR16.12* per share 47 599
d. Aggregated information: Total Volume:
ZAR767 295.88 47 599
e. Transaction date: 6 December 2024
f. Place of transaction: Johannesburg Stock Exchange
Information disclosed in accordance with the JSE Listings Requirements
Nature of interest: Direct, beneficial
Clearance to deal: Yes
* Using the closing market price of ZAR16.12 on 6 December 2024
Paphos, Cyprus
25 February 2025
JSE Sponsor
Investec Bank Limited
Connect with us on LinkedIn
(https://protect-za.mimecast.com/s/Hc4jCJZK7oIYv07fVi1n3?domain=linkedin.com)
and Twitter
(https://protect-za.mimecast.com/s/hll5CKO75pfnN3jUvSAEZ?domain=twitter.com)
to get further news and updates about our business.
Investor Relations Contacts:
Ilja Graulich (Head of Investor Relations and Communications)
+27 11 996 3500
+27 83 604 0820
igraulich@tharisa.com (mailto:igraulich@tharisa.com)
Broker Contacts:
Peel Hunt LLP (UK Joint Broker)
Ross Allister / Georgia Langoulant
+44 207 7418 8900
BMO Capital Markets Limited (UK Joint Broker)
Thomas Rider / Nick Macann
+44 207 236 1010
Berenberg (UK Joint Broker)
Matthew Armitt / Jennifer Lee / Detlir Elezi
+44 203 207 7800
About Tharisa
Tharisa is an integrated resource group critical to the energy transition and
decarbonisation of economies. It incorporates exploration, mining, processing
and the beneficiation, marketing, sales and logistics of PGMs and chrome
concentrates, using innovation and technology as enablers. Its principal
operating asset is the multi-generational Tharisa Mine, located in the
south-western limb of the Bushveld Complex, South Africa. Tharisa is also
developing the Karo Platinum Project, a low-cost, open-pit PGM asset located
on the Great Dyke in Zimbabwe, while simultaneously focusing on beneficiation
in the form of chrome and PGM alloys. A 15-year Power Purchase Agreement with
Etana for the procurement of wheeled renewable energy and a 40 MW solar
project under construction will ensure that Tharisa Minerals' drive to reduce
its carbon footprint by 30% by 2030 is well within reach, forming a major part
of a roadmap to become net carbon neutral by 2050. Redox One is accelerating
the development of a proprietary iron chromium redox flow long-duration
battery utilising the commodities we mine. Tharisa plc is listed on the
Johannesburg Stock Exchange (JSE: THA) and the Main Board of the London Stock
Exchange (LSE: THS).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHZZLFLELLEBBL